We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Certolizumab pegol

Australian Public Assessment Report

AusPAR

AusPAR: Certolizumab pegol [PDF, 1.78 MB]

AusPAR: Certolizumab pegol [Word, 1.42 MB]

Attachment: Product Information: Certolizumab pegol [PDF, 438.33 KB]

Attachment: Product Information: Certolizumab pegol [Word, 182.01 KB]

Attachment: Extract from the Clinical Evaluation Report for Certolizumab pegol [PDF, 2.21 MB]

Attachment: Extract from the Clinical Evaluation Report for Certolizumab pegol [Word, 4.95 MB]

Device/Product Name

Cimzia

Active ingredients

Certolizumab pegol

AusPAR Date

21 June 2017

Published

17 July 2017

Submission Number

PM-2015-01158-1-3

Submission Type

Extension of indications